Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, will cut 9,000 jobs or 11.5% of its workforce in a restructuring to save some $1.3 billion annually, as it battles rising pressure from U.S. rival Eli Lilly.Novo, which was at one point last year Europe’s most valuab




